Feed on
Posts
Comments

IVC and Cancer

From the National Institutes of Health (NIH) has come more evidence that injectible vitamin C might be a powerful weapon in the fight against cancer.  The report was published in the August 5, 2008 issue of the Proceedings of the National Academy of Sciences:  http://www.nih.gov/news/health/aug2008/niddk-04.htm .

In this mouse study, cancers of the pancreas, brain and ovary were shrunk by 41-53% when the mice were given very high doses of intravenous vitamin C.  Just as importantly, the non-cancer cells around the tumors were unharmed.   This is in keeping with other studies that show that intravenous vitamin C (but not oral vitamin C) can slow down and kill cancer cells while protecting normal cells.   Definitive human studies haven’t been done yet, but this is very promising.

We’ve used an intravenous vitamin C protocol in a number of our cancer patients, in the hopes of aiding their primary anticancer therapy and of improving the quality of their lives.  Our protocol is similar to the one now in Phase II trials at the University of Kansas, which is looking further at the safety and efficacy of giving high-dose injectible vitamin C. http://www.clinicaltrials.gov/ct2/show/NCT00284427 .

The use of intravenous vitamin C in cancer got a boost a few years ago when it was discovered that the levels of vitamin C in the cells were many times higher if it is given intravenously, than if the same doses are given orally.  At those very high doses, vitamin C no longer acts as an antioxidant, but actually seems to be lethal to cancer cells. 

As in the University of Kansas study, intravenous vitamin C treatments are given at least 2-3 times per week, and are given slowly and carefully since the amount of time that the cells are exposed to the vitamin C is important. 

Be Sociable, Share!

Trackback URI | Comments RSS

Leave a Reply